BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2972427)

  • 1. The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+.
    De Berardinis P; Londei M; Kahan M; Balsano F; Kontiainen S; Gale EA; Bottazzo GF; Feldmann M
    Clin Exp Immunol; 1988 Aug; 73(2):255-9. PubMed ID: 2972427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus.
    al-Kassab AS; Raziuddin S
    Clin Exp Immunol; 1990 Aug; 81(2):267-71. PubMed ID: 1696864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation.
    Damle NK; Childs AL; Doyle LV
    J Immunol; 1987 Sep; 139(5):1501-8. PubMed ID: 2887618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
    Gessl A; Waldhäusl W
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant activation of CD8+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM.
    Hehmke B; Michaelis D; Gens E; Laube F; Kohnert KD
    Diabetes; 1995 Dec; 44(12):1414-9. PubMed ID: 7589848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal T-lymphocyte subsets in type I diabetes.
    Faustman D; Eisenbarth G; Daley J; Breitmeyer J
    Diabetes; 1989 Nov; 38(11):1462-8. PubMed ID: 2533573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-lymphocyte subpopulations in insulin-dependent (type I) diabetes mellitus.
    Pontesilli O; Chase HP; Carotenuto P; Herberger MJ; Hayward AR
    Clin Exp Immunol; 1986 Jan; 63(1):68-72. PubMed ID: 2937583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal lymphocyte subsets in Kuwaiti patients with type-1 insulin-dependent diabetes mellitus and their first-degree relatives.
    Kaaba SA; Al-Harbi SA
    Immunol Lett; 1995 Sep; 47(3):209-13. PubMed ID: 8747721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.
    Raziuddin S; Elawad ME
    Clin Exp Immunol; 1990 Jan; 79(1):67-71. PubMed ID: 1967994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte activation is associated with viral replication in chronic hepatitis B virus infection of childhood.
    Vegnente A; Guida S; Lobo-Yeo A; Alviggi L; Daniels H; Toscano P; Nuzzo V; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 1991 May; 84(2):190-4. PubMed ID: 1827371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis.
    Bengtsson M; Tötterman TH; Smedmyr B; Festin R; Oberg G; Simonsson B
    Leukemia; 1989 Jan; 3(1):68-75. PubMed ID: 2535882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease.
    Yoshikawa N; Morita T; Arreaza G; Resetkova E; Mukuta T; Volpé R
    Clin Invest Med; 1995 Apr; 18(2):91-8. PubMed ID: 7788961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of the CD45R (2H4) molecule on CD8 (T8) cells in the autologous mixed lymphocyte reaction system.
    Takeuchi T; Rudd CE; Tanaka S; Rothstein DM; Schlossman SF; Morimoto C
    Eur J Immunol; 1989 Apr; 19(4):747-55. PubMed ID: 2567246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis.
    Odum N; Morling N; Platz P; Hofmann B; Ryder LP; Heilmann C; Pedersen FK; Nielsen LP; Friis J; Svejgaard A
    Ann Rheum Dis; 1987 Nov; 46(11):846-52. PubMed ID: 2827591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective inducer T-cell function before the onset of insulin-dependent diabetes mellitus.
    Schatz DA; Riley WJ; Maclaren NK; Barrett DJ
    J Autoimmun; 1991 Feb; 4(1):125-36. PubMed ID: 1827712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro study of expression of interleukin-2 receptors in T-lymphocytes from patients with IgA nephropathy.
    Lai KN; Leung JC; Lai FM
    Clin Nephrol; 1988 Dec; 30(6):330-4. PubMed ID: 2977310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus.
    Petersen LD; Duinkerken G; Bruining GJ; van Lier RA; de Vries RR; Roep BO
    J Autoimmun; 1996 Dec; 9(6):731-7. PubMed ID: 9115575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.
    Ilonen J; Surcel HM; Käär ML
    Clin Exp Immunol; 1991 Aug; 85(2):278-81. PubMed ID: 1677834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial meningitis: T cell activation and immunoregulatory CD4+ T cell subset alteration.
    Raziuddin S; el-Awad ME; Mir NA
    J Allergy Clin Immunol; 1991 Jun; 87(6):1115-20. PubMed ID: 1710632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of impaired B- and T-lymphocyte subsets and functions in vitro by isoprinosine in prodromal homosexuals and AIDS patients.
    Tsang PH; Zanjani MD; Warner N; Bekesi JG
    J Clin Lab Immunol; 1986 Aug; 20(4):159-65. PubMed ID: 2428980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.